BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38693041)

  • 1. K-ras mutation detected by peptide nucleic acid-clamping polymerase chain reaction, Ki-67, S100P, and SMAD4 expression can improve the diagnostic accuracy of inconclusive pancreatic EUS-FNB specimens.
    Kim BH; Kwon M; Lee D; Park SW; Shin E
    Pancreatology; 2024 Apr; ():. PubMed ID: 38693041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS mutation analysis by next-generation sequencing in endoscopic ultrasound-guided sampling for solid liver masses.
    Choi HJ; Moon JH; Kim HK; Lee YN; Lee TH; Cha SW; Cho YD; Park SH
    J Gastroenterol Hepatol; 2017 Jan; 32(1):154-162. PubMed ID: 27118240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
    Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
    PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.
    Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A
    Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA.
    Cazacu IM; Semaan A; Stephens B; Swartzlander DB; Guerrero PA; Singh BS; Lungulescu CV; Danciulescu MM; Cherciu Harbiyeli IF; Streata I; Popescu C; Saftoiu A; Roy-Chowdhuri S; Maitra A; Bhutani MS
    Gastrointest Endosc; 2021 May; 93(5):1142-1151.e2. PubMed ID: 33058885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
    Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
    World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study of the Diagnostic Utility of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology (EUS-FNA) versus Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) in Pancreatic and Non-Pancreatic Lesions.
    Yousri M; Abusinna E; Tahoun N; Okasha HH; El-Habashi AH
    Asian Pac J Cancer Prev; 2022 Jun; 23(6):2151-2158. PubMed ID: 35763660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma.
    Sweeney J; Rao R; Margolskee E; Goyal A; Heymann JJ; Siddiqui MT
    J Am Soc Cytopathol; 2018; 7(6):318-323. PubMed ID: 31043302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration.
    Dim DC; Jiang F; Qiu Q; Li T; Darwin P; Rodgers WH; Peng HQ
    Diagn Cytopathol; 2014 Mar; 42(3):193-9. PubMed ID: 21538952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
    Gan Q; Roy-Chowdhuri S; Duose DY; Stewart JM; Coronel E; Bhutani MS; Lee JH; Weston B; Ge PS; Ross WA; Maitra A
    Cancer Cytopathol; 2022 Apr; 130(4):275-283. PubMed ID: 34905283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
    Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
    Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis.
    Tamura T; Ashida R; Wan K; Shimokawa T; Kitano M
    Pancreatology; 2024 Feb; 24(1):78-87. PubMed ID: 38042675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional K-ras mutation analysis and Plectin-1 staining improve the diagnostic accuracy of pancreatic solid mass in EUS-guided fine needle aspiration.
    Park JK; Paik WH; Song BJ; Ryu JK; Kim MA; Park JM; Lee SH; Kim YT
    Oncotarget; 2017 Sep; 8(38):64440-64448. PubMed ID: 28969083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Furuhata A; Minamiguchi S; Shirahase H; Kodama Y; Adachi S; Sakurai T; Haga H
    Pancreas; 2017 Apr; 46(4):531-538. PubMed ID: 28099249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
    Xu Y; Hu D; Zhu Q; Sun Y
    Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma.
    Park JK; Lee YJ; Lee JK; Lee KT; Choi YL; Lee KH
    Oncotarget; 2017 Jan; 8(2):3519-3527. PubMed ID: 27974679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous ultrasound and endoscopic ultrasound-guided biopsy of solid pancreatic lesions: An analysis of 1074 lesions.
    Chai WL; Kuang XF; Yu L; Cheng C; Jin XY; Zhao QY; Jiang TA
    Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):302-309. PubMed ID: 35817668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUS-guided reverse bevel fine-needle biopsy sampling and open tip fine-needle aspiration in solid pancreatic lesions - a prospective, comparative study.
    Hedenström P; Demir A; Khodakaram K; Nilsson O; Sadik R
    Scand J Gastroenterol; 2018 Feb; 53(2):231-237. PubMed ID: 29301477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic ultrasound-guided tissue acquisition with or without rapid on-site evaluation for solid pancreatic lesions: five years of experience from a single center.
    Liu Y; Xiong D; Zhao Y; Meng Z; Wu X; Jiang Q; Wang Q; Wu D; Zhang S; Feng Y; Yang A
    Scand J Gastroenterol; 2023; 58(10):1185-1193. PubMed ID: 37114616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors.
    Crinò SF; Ammendola S; Meneghetti A; Bernardoni L; Conti Bellocchi MC; Gabbrielli A; Landoni L; Paiella S; Pin F; Parisi A; Mastrosimini MG; Amodio A; Frulloni L; Facciorusso A; Larghi A; Manfrin E
    Pancreatology; 2021 Mar; 21(2):443-450. PubMed ID: 33390343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.